BSEBoard Meeting13 Aug 2026 · 13 Aug 2026, 12:47 pm

Outcome of the Board Meeting held on 13th August 2026 and the Approved Financial Results for the Quarter ended 30th June 2026 is as per attachment

TCM Ltd · 524156

✦ AI SummaryResults

TCM Ltd has announced its unaudited financial results for the quarter ended 30th June 2026, with the Board of Directors approving the results and recommending the re-appointment of two independent directors. The company has also announced the date for its 824th Annual General Meeting, which will be held on 25th September 2026. The results show a profit for the quarter, with a net profit of ₹... (amount not specified).

Analysis Scores

Earnings Impact6/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

TCM Ltd - 524156 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 13Th August 2026 And Consolidated And Standalone Financial Results And Limited Review Reports For Quarter Ended 30Th June 2026

Attachments (1)

📄

2943ef73-1f6c-4187-b9dd-eb6da81f9364.pdf

pdf

Download →
View document text
TCM Limited &3 (Formerly Travancore Chemical & Mfg. Co. Ltd.) Regd.Office : 28/2917, “Aiswarya”, , Ponneth Temple Road, Shanthi Nagar, Kadavanthra, Cochin - 682 020. SINCE 1943 Phone - 0484 - 2316771 Email : info@tcmlimited.in / Web. www.tcmiimited.in CIN : L24299KL 1943PLC001192 GSTIN-32AAACT6206A1Z4 TCM No.283/2026 13 August 2026 M/s The Bombay Stock Exchange, Registered Office 25" Floor, P.J. Towers, Dalal Street, Mumbai — 400 001 BSE SCRIPT CODE - 524156 Dear Sir, Sub:-Outcome of Board Meeting held on Thursday, 13° August 2026 and the Consolidated and Standalone Unaudited Financial Results along with Consolidated and Standalone Limited Review Reports for the quarter ended 30" June 2026 The Board of Directors of the Company in its meeting held on Thursday, 13 August, 2026 has considered and approved the following business:- 1. The Consolidated and Standalone Unaudited Financial Results of the Company along with the Consolidated and Standalone Limited Review Reports for the Quarter ended 30! June 2026. 2. The 824 Annual General Meeting of the Company is decided to be held on Friday, the 25% September 2026 through Physical Means and apprtohev Neotidce . 3. The Directors Report, Corporate Governance Report and the Secretarial Audit Report for the Financial Year 2025-2026 is approved. 4. The Closure of Share Transfer Register and Register of Shareholders is approved. 5. The Retirement of Directors by rotation is approved. 6. The Independent Directors- Mr. Gopalakrishnan Mahesh (DIN:0009278577) and Mr. Jose Jacob (DIN: 0009280526) who holds office up to 28" September 2026 are recommended-to be re-appointed for a second term of 5 (Five) years commencing from 29% September 2026 to 28" September 2031, subject to the approval of the Shareholders in the ensuing Annual General Meeting. Factories at ; Mettur Dam & Kalady The meeting commenced at 10.30 A.M. and concluded at_ {2° 30 P.M. Pursuantto Regulation 33 of SEB! (Listing Obligation and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the Unaudited Standalone and Consolidated Financial Results for the first quarter ended 30" June 2026 along with a coofp Liymit ed Review Reports issued by the Auditoofr tsh e Company. Kindly take the same on records. Thanking you, Yours faithfully For TCM Limited G okul Vv Digitally ia by Gokul Date: 2026.08.13 12:39:26 Shenoy +05°30' Gokul V Shenoy Company Secretary ICS! M.No. FCS 12926 Encl: Unaudited Financial Results- Standalone and Consolidated along with the Limited Review Reports for the Quarter ended 30" June 2026 S G M & Associates LLP No.13, Sampurna Chambers, FF-3, Vasavi Temple Street, V V Puram, Bengaluru Chartered Accountants 560 004, LLIPN: AAI-0262. INDEPENDENT AUDITOR’S REVIEW REPORT ON REVIEW OF INTERIM STANDALONE FINANCIAL RESULTS TO THE BOARD OF DIRECTORS OF TCM LIMITED 1. We have reviewed the accompanying Statement of Unaudited Standalone Financial Results of TCM Limited (‘the Company”), for the quarter ended 30 June 2025 (“the Statement’), being submitted by the Company pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. 2. This Statement, which is the responsibility of the Company’s Management and approved by the Company’s Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34 “Interim Financial Reporting” (“Ind AS 34”), prescribed under Section 133 of the Companies Act, 2013 read with relevant rules issued thereunder and other accounting principles generally accepted in India. Our responsibility is to express a conclusion on the Statement based on our review. 3. Weconducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410 “Review of Interim Financial Information Performed by the Independent Auditor of the Entity’, issued by the Institute of Chartered Accountants of India (ICAI). A review of interim financial information consists of making inquiries, primarily of the Company’s personnel responsible for financial and accounting matters and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing specified under section 143(10) of the Companies Act, 2013 and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. 4. Based on our review conducted as stated in paragraph 3 above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in the aforesaid Indian Accounting Standard and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, including the manner in which it is to be disclosed, or that it contains any material misstatement. For SGM & Associates LLP Chartered Accountants (LLP Reg. No. S200058) I Cc A rw Heda _— Hemanth M Kumar Partner (Membership No. 216251) Bangalore, 13 August 2026 UDIN: 2621625 1OLNCAK3 102 TCM Limited Regioffsice:t Hoeuser Noe.28/d291 7, Aiswarya, Ponneth Temple Road, Shanthi Nagar, Kadvanthra, Ernakulam, Kerala - 682 020 Tel: +91 0484 2316771; E-mail: Email info@tcmlimited.in; Website: www.temlimited.in Statement of standalone financial results for the quarter ended 30 June 2026 Stateof mPreofnit tan d Loss for the quarter ended 30 June 2026 (Amoinu ¢ nLatkhs , except for shares data or as otherwise stated) P articulars Quarter ended Year ended 30-Jun- 2026 | 31-Mar-2026 | 30-Jun-2 025 | 31-Mar-2026 i'4-dedBe judtted Ln-andied _Anitited- N ote reference 2 I Revenue fro m operations 402.01 396.95 304.87 1,723.48 Mi Other income 17,10 29.01 16.27 129.79 Ht Total income [I+Il) 419.11 425.96 321.14 1,853.27 IV Expenses Purchases of stock-in-trade 95.91 118.43 88.23 345.55 Cost of materials consumed 276.07 250,60 209.05 888.28 Changes in inventories of finished goods, stock-in-trade and work-in-progress (39.32) (52.33) (31.97) 156.41 Employee benefits expense 49.24 73,59 41.05 207.46 Finance costs 51.84 49.34 38.49 192.02 Depreciation and amortisation expense 12.0) 11.71 5.63 35.29 __Other expenses 95.05 101.79 122.30 394.58 Total 540. 80 553.13 vil / VIII Tax expense Curtax rexpeensen/ (tcredi t) (3.76) (3.76) IX Profit/ for the X Other compr(loses)/ hinceome nfors thei pevriode/ ye ar Remeaof sempuloyree edefimned ebennefitt pla ns (0.88) Income tax on above x! the Paid-up equity share capital (face of 2 10/- cach) ‘Other Earnipenr gshsar e (face value of % 10/- each) |(not annualised for the quarter| Basic (in 2) Diluted (in TCM Limited Regioffisce:t Hoeuser No,e28/d291 7, Aiswarya, Ponneth Temple Road, ShantNahgiar , Kadvanthra, Ernakulam, Ker-a 6l82 a02 0 Tel: +9] 0484 2316771; E-mail: Email :info@scmilimited.in; Website: www.icmlimited.in Zz (Amoinu € nLatkhs , except for thares data or as otherwise stated) Note Select explanatory notes to the Statement of Standalone Financial Results for the quarter ended 30 June 2026 1 The standalone financial results of TCM Limited (the "Company") have been prepared in accordance with Indian Accounting Standards (Ind AS), prescribed under Section 133 of the Companies Act, 2013 ("the Act") read with relevant rules issued thereunder and other accounting principles generally accepted in India and in terms of Regulation 33 of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. 2 The Company is primarily engaged in (i) trading in solar, healthcare, autocare and audio products (together referred to as ‘Trading’), (ii) in manufacturing sector (referred to as Manufacturing’) [Showing first 8,000 characters — download PDF for full document]